Yayın:
Body fat, dyslipidemia, blood pressure and the effects of smoking in Germans and Turks

dc.contributor.authorCan, Guenay
dc.contributor.authorSchwandt, Peter
dc.contributor.authorOnat, Altan
dc.contributor.authorHergenc, Guelay
dc.contributor.authorHaas, Gerda-Maria
dc.date.accessioned2026-06-27T13:09:42Z
dc.date.issued2009
dc.description.abstractAim: Determining the difference regarding obesity in German and Turkish adults. Materials and Methods: This study examined a cross-section of adults aged 30-79 years old. Age-adjustment was uniformly provided for comparisons. Results: Among 3055 Germans and 2925 Turks, Turkish women had significantly higher markers of (abdominal) obesity than German women, while waist circumference (WC) was similar among males. Blood pressure (BP), concentrations of total, LDL-cholesterol, and apolipoprotein B were significantly higher among Germans, whereas Turks had markedly higher fasting triglycerides and lower HDL-cholesterol. Unlike Germans, the current trend of smoking among Turks correlates with lower WC and lower systolic BP compared to non-smokers. Hip circumference was associated positively with atherogenic dyslipidemia more strongly among Germans than Turks. Changes in circumferences of waist and hip were significantly associated with elevated LDL-cholesterol, independent of BMI, in Germans, but not among Turks. Excess of overall obesity in Germans and Turkish females, and abdominal obesity among Turkish men, in addition to different sex, appeared to be major determinants of SBP In contrast to Germans and Turkish males, atherogenic dyslipidemia was significantly associated with higher SBP in Turkish females. Conclusions: Distribution of adiposity, and its interrelationship in German and Turkish adults, reveals substantial disparity that reflects pathogenetic differences; this requires modified emphasis of preventive and therapeutic measures.en
dc.description.sponsorshipTurkish Society of Cardiology and the pharmaceutical companies in Istanbul, Turkey
dc.description.sponsorshipPfizer
dc.description.sponsorshipAstraZeneca
dc.description.sponsorshipSanofiAventis
dc.description.sponsorshipNovartis
dc.description.sponsorshipPublic Foundation for the Prevention of Atherosclerosis
dc.description.sponsorshipLudwig-Maximilians-University Munich
dc.description.sponsorshipBavarian Ministry of Health
dc.description.sponsorshipCity of Nuremberg
dc.description.sponsorshipAOK Bavaria
dc.description.sponsorshipLVA Oberbayern
dc.description.sponsorshipOber-Mittelfranken
dc.description.sponsorshipBanns Stiftung
dc.description.sponsorshipFriedrich Baur-Stiftung
dc.description.urihttps://doi.org/10.3906/sag-0809-16
dc.identifier.doi10.3906/sag-0809-16
dc.identifier.eissn1303-6165
dc.identifier.endpage589
dc.identifier.issn1300-0144
dc.identifier.issue4
dc.identifier.startpage579
dc.identifier.urihttps://hdl.handle.net/20.500.14981/50573
dc.identifier.volume39
dc.identifier.wos000271094700013
dc.language.isoeng
dc.publisherTubitak Scientific & Technological Research Council Turkey
dc.relation.ispartofTURKISH JOURNAL OF MEDICAL SCIENCES
dc.rightsopenAccess
dc.subjectBlood pressure
dc.subjectdyslipidemia
dc.subjectethnicity
dc.subjectmetabolic syndrome
dc.subjectobesity
dc.subjectsmoking habit
dc.subjectCORONARY-HEART-DISEASE
dc.subjectRISK-FACTORS
dc.subjectABDOMINAL OBESITY
dc.subjectCARDIOVASCULAR-DISEASE
dc.subjectCARDIOMETABOLIC RISK
dc.subjectWAIST CIRCUMFERENCE
dc.subjectCHOLESTEROL LEVELS
dc.subjectPOPULATION
dc.subjectADULTS
dc.subjectGeneral & Internal Medicine
dc.titleBody fat, dyslipidemia, blood pressure and the effects of smoking in Germans and Turks
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar